| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.06 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.06 | 0.07 |